Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-responders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00292084
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Large-scale testing (Phase 3)UnknownNCT00336518
What this trial is testing

Continuing Treatment With Pegasys and Copegus

Who this might be right for
Chronic Hepatitis C
Májbetegekért Alapítvány 100
Early research (Phase 1)Study completedNCT01387594
What this trial is testing

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Who this might be right for
Crohn's DiseaseIleitisIleo-colonic and Colonic Crohn's Disease+3 more
Shire 49
Testing effectiveness (Phase 2)Study completedNCT01919086
What this trial is testing

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Memorial Sloan Kettering Cancer Center 30
Not applicableEnded earlyNCT03789487
What this trial is testing

Electrical Optimization of Cardiac Resynchronization Therapy in Non-responder Patients

Who this might be right for
Heart FailureCardiac Resynchronization Therapy
CMC Ambroise Paré 27
Post-approval studies (Phase 4)Study completedNCT03779048
What this trial is testing

Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment

Who this might be right for
Obesity
University of Pennsylvania 147
Not applicableActive Not RecruitingNCT04100148
What this trial is testing

SyncAV Post-Market Trial

Who this might be right for
Congestive Heart Failure
Abbott Medical Devices 1,686
Post-approval studies (Phase 4)Study completedNCT00530972
What this trial is testing

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Who this might be right for
Chronic Hepatitis CHIV Infections
Hospital Carlos III, Madrid 50
Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372
Not applicableStudy completedNCT01059175
What this trial is testing

Dual-Site LV Pacing in CRT Non Responders: Multicenter Randomized Trial

Who this might be right for
Heart Failure
Medtronic Cardiac Rhythm and Heart Failure 84
Not applicableStudy completedNCT01806870
What this trial is testing

Immune Enhancement for Immunological Non-responders to ART

Who this might be right for
HIV
Emory University 30
Very early researchStudy completedNCT03202537
What this trial is testing

Effectiveness of Physiologic Testing in PPI Non-Responders

Who this might be right for
Gastro Esophageal Reflux
Northwestern University 240
Large-scale testing (Phase 3)Study completedNCT06179875
What this trial is testing

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 139
Not applicableUnknownNCT01361841
What this trial is testing

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

Who this might be right for
Ocular HypertensionPrimary Glaucoma
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 141
Large-scale testing (Phase 3)Study completedNCT02822742
What this trial is testing

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 26
Not applicableStudy completedNCT00965705
What this trial is testing

Stepped Care Treatment for Binge-Eating

Who this might be right for
Binge Eating Disorder
Temple University 109
Testing effectiveness (Phase 2)Looking for participantsNCT07637877
What this trial is testing

Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study

Who this might be right for
Immunological Non-Responders in People With HIV
Beijing 302 Hospital 21
Testing effectiveness (Phase 2)Looking for participantsNCT07438405
What this trial is testing

An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Amgen 30
Not applicableNot Yet RecruitingNCT07428109
What this trial is testing

Artificial Intelligence Triage of Patients Requiring Emergency or Unscheduled Care Who Need to be Referred to Hospital

Who this might be right for
Need to Refer the Patient to the Hospital Emergency Department
SOS Médecins Grand Paris 40,680
Not applicableStudy completedNCT03663400
What this trial is testing

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

Who this might be right for
Ulcerative Colitis
NYU Langone Health 47
Next Page